Literature DB >> 11957029

Nocardia asteroides isolated from three patients with cystic fibrosis.

R Lumb1, H Greville, J Martin, N Sangster, M Holmes.   

Abstract

Over a 7-year period, three patients with cystic fibrosis had multiple sputum specimens that were smear- and culture-positive for Nocardia asteroides. Two of the patients had received long-term, low-dose inhalational corticosteroid therapy. Although all three patients were treated with cotrimoxazole, resulting in eradication of the organism from the sputum, there was no change in their clinical state, radiological findings, or pulmonary function. The isolation of Nocardia asteroides from the respiratory tract of cystic fibrosis patients is an unusual finding. Its presence does not necessarily imply disease, and in these three cases, it most likely represented colonisation. The clinical significance of Nocardia spp. isolated from the respiratory tract of cystic fibrosis patients needs to be considered in the context of the individual clinical picture.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11957029     DOI: 10.1007/s10096-001-0687-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  A French multicentric study and review of pulmonary Nocardia spp. in cystic fibrosis patients.

Authors:  Verónica Rodriguez-Nava; Stéphane Durupt; Sandra Chyderiotis; Anne-Marie Freydière; Judith Karsenty; Michèle de Montclos; Philippe Reix; Isabelle Durieu; Raphaele Nove-Josserand; Raphael Chiron; François Bremont; Laurent Têtu; Marlène Murris; Dominique Terru; Sylvain Godreuil; Emmanuelle Bergeron; Jean Freney; Patrick Boiron; François Vandenesch; Hélène Marchandin; Christine Segonds; Anne Doléans-Jordheim
Journal:  Med Microbiol Immunol       Date:  2014-10-26       Impact factor: 3.402

3.  Nocardia farcinica lung infection in a patient with cystic fibrosis: a case report.

Authors:  Fadi Bittar; Nathalie Stremler; Jean-Pierre Audié; Jean-Christophe Dubus; Jacques Sarles; Didier Raoult; Jean-Marc Rolain
Journal:  J Med Case Rep       Date:  2010-03-08

4.  Secular trends of nocardia infection over 15 years in a tertiary care hospital.

Authors:  R Matulionyte; P Rohner; I Uçkay; D Lew; J Garbino
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

5.  Nocardia Colonization: A Risk Factor for Lung Deterioration in Cystic Fibrosis Patients?

Authors:  Adi Dagan; Nathan Keller; Daphna Vilozni; Reut Ramon-Saraf; Bat-El Bar; Ifat Sarouk; Moshe Ashkenazi; Moran Lavie; Ori Efrati
Journal:  Med Sci Monit       Date:  2015-06-30

6.  Pulmonary nocardiosis in an immunocompetent patient with cystic fibrosis.

Authors:  Lucy Schoen; Jonathan D Santoro; Carlos Milla; Sumit Bhargava
Journal:  Case Rep Pulmonol       Date:  2015-04-15

7.  Clinical significance, antimicrobial susceptibility and molecular identification of Nocardia species isolated from children with cystic fibrosis.

Authors:  Ana Betrán; M Cruz Villuendas; Antonio Rezusta; Javier Pereira; M José Revillo; Verónica Rodríguez-Nava
Journal:  Braz J Microbiol       Date:  2016-04-19       Impact factor: 2.476

8.  Nocardia polymerase chain reaction (PCR)-based assay performed on bronchoalveolar lavage fluid after lung transplantation: A prospective pilot study.

Authors:  Julien Coussement; David Lebeaux; Najla El Bizri; Vincent Claes; Michel Kohnen; Deborah Steensels; Isabelle Étienne; Hélène Salord; Emmanuelle Bergeron; Veronica Rodriguez-Nava
Journal:  PLoS One       Date:  2019-02-25       Impact factor: 3.240

9.  A case of Nocardia transvalensis pneumonia in a 19-year-old cystic fibrosis patient.

Authors:  Avinash Aravantagi; Kamakshya P Patra; Marlene Broussard; Kimberly Jones
Journal:  Lung India       Date:  2012-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.